Host systemic and local nitric oxide levels do not correlate with rejection of pig proislet xenografts in mice
Charmaine J. Simeonovic
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorDamien V. Cordery
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorBarbara Van Leeuwen
Division of Biochemistry and Molecular Biology, The Faculty of Science, The Australian National University, Canberra, Australia,
Search for more papers by this authorSarah K. Popp
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorMichelle J. Townsend
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorMichelle F. Paule
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorJ. Dennis Wilson
Department of Endocrinology, The Canberra Hospital, Woden, Australia
Search for more papers by this authorWilliam B. Cowden
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorCharmaine J. Simeonovic
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorDamien V. Cordery
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorBarbara Van Leeuwen
Division of Biochemistry and Molecular Biology, The Faculty of Science, The Australian National University, Canberra, Australia,
Search for more papers by this authorSarah K. Popp
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorMichelle J. Townsend
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorMichelle F. Paule
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorJ. Dennis Wilson
Department of Endocrinology, The Canberra Hospital, Woden, Australia
Search for more papers by this authorWilliam B. Cowden
Division of Molecular Medicine and Immunology and Cell Biology, The John Curtin School of Medical Research, Canberra, Australia,
Search for more papers by this authorAbstract
The rejection of pig proislet xenografts in mice is a CD4 T cell-dependent process in which macrophages play an important role. To assess the potential for activated macrophages to act as effector cells in xenograft destruction, we have examined the relationship between proislet xenograft rejection, two principal markers of macrophage activation, transcription of inducible nitric oxide synthase (iNOS) and production of nitric oxide (NO), and their temporal relationship to intragraft cytokine gene expression. Xenograft rejection in CBA/H mice correlated with early induction of intragraft host iNOS mRNA and marked intragraft production of NO (reactive nitrogen intermediates, RNI). Intragraft mRNA expression for IFN-γ, IL-1β and TNF, cytokines associated with macrophage activation, was also found. These findings suggested that activated macrophages could be contributing to xenograft destruction via local NO-mediated toxicity at the graft site.To test the role of NO in this model: (1) Q-fever antigen (QFA) was administered to recipient mice in order to induce high systemic RNI levels and (2) in another experiment, pig proislets were transplanted into iNOS−/− mice. Treatment with QFA correlated with prolonged xenograft survival at 7 days post-transplant. Splenocytes from QFA-treated, but not control mice at 7 and 22 days post-transplant, exhibited inhibition of secondary xenogeneic mouse antiporcine mixed lymphocyte reaction (MLR) that was reversed by culture with the NOS inhibitor N-methylarginine (NMA). Despite continued elevated NO production, xenograft protection was temporary with complete rejection by day 22. Evidence that locally produced NO was not contributing to rejection was seen when pig proislets transplanted into iNOS−/− mice were rejected with normal kinetics; in these animals intragraft NO production was not detected (despite porcine iNOS gene expression). Failure of activated macrophages to achieve indefinite xenograft survival suggests that other factors are also required. Macrophage potential to effect either destructive or protective roles after pig proislet xenotransplantation suggests that such functions may depend on the site and magnitude of macrophage activation. Together these findings clearly demonstrate that high NO levels in the periphery are not damaging to xenogeneic islet tissue, neither host nor donor NO production is essential for islet xenograft rejection and consequently elevated plasma RNI levels do not represent a direct marker for rejection.
References
- 1 WILSON JD, SIMEONOVIC CJ, TING JHL, CEREDIG R. Role of CD4+ T-lymphocytes in rejection by mice of fetal pig proislet xenografts. Diabetes 1989; 38 (Suppl. 1): 217217.
- 2 SIMEONOVIC CJ, CEREDIG R, WILSON JD. Effect of GK1.5 monoclonal antibody dosage on survival of pig proislet xenografts in CD4+ T cell-depleted mice. Transplantation 1990; 49: 849849.
- 3 SIMEONOVIC CJ, WILSON JD, CEREDIG R. Antibody- induced rejection of pig proislet xenografts in CD4+ T cell-depleted diabetic mice. Transplantation 1990; 50: 657657.
- 4 SIMEONOVIC CJ, MCKENZIE KUS, WILSON JD, ZARB JC, HODGKIN PD. Role of anti-donor antibody in the rejection of pig proislet xenografts in mice. Xenotransplantation 1998; 5: 1818.
- 5 BENDA B, KARLSSON-PARRA A, RIDDERSTAD A, KORSGREN O. Xenograft rejection of porcine islet-like cell clusters in immunoglobulin- or Fc-receptor γ- deficient mice. Transplantation 1996; 62: 12071207.
- 6 MORRIS CF, SIMEONOVIC CJ, FUNG M-C, WILSON JD, HAPEL AJ. Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice. J Immunol 1995; 154: 24702470.
- 7 KARLSSON-PARRA A, RIDDERSTAD A, WALLGREN AC, MOLLER E, JUNGGREN HG, KORSGREN O. Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation 1996; 61: 13131313.
- 8 SIMEONOVIC CJ, TOWNSEND MJ, WILSON JD et al. Eosinophils are not required for the rejection of neovascularised fetal pig proislet xenografts in mice. J Immunol 1997; 158: 24902490.
- 9 FOX A, KOULMANDA M, MANDEL TE, VAN ROOIJEN N, HARRISON LC. Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice. Transplantation 1998; 66: 14071407.
- 10 MOSES RD, PIERSON RNI, WINN HJ, AUCHINCLOSS H JR. Xenogeneic proliferation and lymphokine production are dependent on CD4+ T helper cells and self antigen-presenting cells in the mouse. J Exp Med 1990; 172: 567567.
- 11 YOSHIZAWA K, YANO A. Mouse T lymphocyte proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR. J Immunol 1984; 132: 28202820.
- 12 CHITILIAN HV, LAUFER TM, STENGER K, SHEA S, AUCHINCLOSS H. The strength of cell-mediated xenograft rejection in the mouse is due to the CD4+ indirect response. Xenotransplantation 1998; 5: 9393.
- 13 KORSGREN O. Acute cellular xenograft rejection. Xenotransplantation 1997; 4: 1111.
- 14 FOX A, HARRISON LC. Innate immunity and graft rejection. Immunol Rev 2000; 173: 141141.DOI: 10.1034/j.1600-065x.2000.917313.x
- 15 STOUT RD. Macrophage activation by T cells: cognate and non-cognate signals. Curr Opin Immunol 1993; 5: 398398.
- 16 LANGREHR JM, HOFFMAN RA, LANCASTER JR, SIMMONS RL. Nitric oxide – a new endogenous immunomodulator. Transplantation 1993; 55: 12051205.
- 17 NATHAN C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 30513051.
- 18 HIBBS JB, TAINTOR RR, VAVRIN Z, RACHLIN EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 8787.
- 19 KRONCKE K-D, RODRIGUEZ M-L, KOLB H, KOLB-BACHOFEN V. Cytotoxicity of activated rat macrophages against syngeneic islet cells is arginine-dependent, correlates with citrulline and nitrite concentrations and is identical to lysis by the nitric oxide donor nitroprusside. Diabetologia 1993; 36: 1717.
- 20 KARUPIAH G, HARRIS N. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J Exp Med 1995; 181: 21712171.
- 21 GREEN SJ, NANCY CA, MELTZER MS. Cytokine-induced synthesis of nitrogen oxide in macrophages: a protective host response to Leishmania and other intracellular pathogens. J Leuk Biol 1991; 50: 9393.
- 22 CORBETT JA, MIKHAEL A, SHIMIZU J et al. Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and – resistant stages in the immunological diabetic process. Proc Natl Acad Sci USA 1993; 90: 89928992.
- 23 STEVENS RB, ANSITE JD, MILLS CD et al. Nitric oxide mediates early dysfunction of rat and mouse islets after transplantation. Transplantation 1996; 61: 17401740.
- 24 MACMICKING JD, NATHAN C, HOM G et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81: 641641.
- 25 KIRKMAN RL, COLVIN RB, FLYE MW et al. Transplantation in miniature swine VI. Factors influencing survival or renal allografts. Transplantation 1979; 28: 1818.
- 26 SIMEONOVIC CJ, BROWN DJ, TEITTINEN KUS, WILSON JD. Preparation and transplantation of fetal proislets. In: RICORDI C, ed. Pancreatic Islet Cell Transplantation. Austin: R.G. Landes Co., 1992.
- 27 ROCKETT KA, AWBURN MM, ROCKETT EJ, COWDEN WB, CLARK IA. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol 1994; 16: 243243.
- 28 PATTHY A, BAJUSZ S, PATTHY L. Preparation and characterisation of NG-mono-, di- and trimethylated arginines. Acta Biochim Biophys Acad Sci Hung 1977; 12: 191191.
- 29 OSWALD IP, ELTOUM I, WYNN TA et al. Endothelial cells are activated by cytokine treatment to kill an intravascular parasite Schistosoma mansoni, through the production of nitric oxide. Proc Natl Acad Sci USA 1994; 91: 999999.
- 30 PAMPUSCH MS, BENNAARS AM, HARSCH S, MURTAUGH MP. Inducible nitric oxide synthase expression in porcine immune cells. Vet Immunol Immunopathol 1998; 61: 279279.
- 31 BISHOP GA, HALL BM, DUGGIN GG, HORVATH JS, SHEIL AG, TILLER DJ. Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int 1986; 29: 708708.
- 32 PIERRES A, NAQUET P, VAN AGTHIVEN A et al. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Ly-2,3- and T4-, Ly-2,3+) subsets among the anti–Ia cytolytic T cell clones. J. Immunol 1984; 132: 27752775.
- 33 LEDBETTER JA, HERZENBERG LA. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979; 47: 6363.
- 34 HOFFMAN RA, LANGREHR JM, BILLIAR TR, CURRAN RD, SIMMONS RL. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metaboism of L-arginine. J Immunol 1990; 145: 22202220.
- 35 CORBETT JA, MCDANIEL ML. Does nitric oxide mediate autoimmune destruction of b-cells? Possible therapeutic interventions in IDDM. Diabetes 1992; 41: 897897.
- 36 KRONCKE KD, KOLB-BACHOFEN V, BERSCHICK B, BURKART V, KOLB H. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun 1991; 175: 752752.
- 37 KOLB H, KOLB-BACHOFEN V. Nitric oxide: a pathogenic factor in autoimmunity. Immunol Today 1992; 13: 157157.
- 38 RAMWELLAND P, THOMAS G. Nitric oxide and its role in transplantation. Transplant Proc 1995; 27: 20742074.
- 39 BRUNE B, DIMMELER S, VEDIA LM, LAPETINA EG. Nitric oxide: a signal for ADP-ribosylation of proteins. Life Sci 1993; 54: 6161.
- 40 FEHSEL K, JALOWY A, QI S, BURKART V, HARTMANN B, KOLB H. Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 1993; 42: 496496.
- 41 LIN Y, VANDEPUTTE M, WAER M. Contribution of activated macrophages to the process of delayed xenograft rejection. Transplantation 1997; 64: 16771677.
- 42 CASEY JJ, WEI X-Q, ORR DJ et al. Skin allograft rejection in mice lacking inducible nitric oxide synthase. Transplantation 1997; 64: 589589.
- 43 BEHBOO R, RICORDI C, LUMACHI F et al. Aminoguanidine inhibits the generation of nitric oxide in vitro and prolongs islet xenograft survival in rats. Transplant Proc 1997; 29: 21522152.
- 44 FENG X, YI S, HAWTHORNE W, PATEL AT, WALTERS SN, O'CONNELL PJ. Inducible nitric oxide synthetase is expressed in adult but not fetal pig pancreatic islets. Xenotransplantation 2000; 7: 197197.
- 45 YANG X, CHOWDHURY N, CAI B et al. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 1994; 94: 714714.
- 46 SZABOLCS MJ, RAVALLI S, MINANOV O, SCIACCA RR, MICHLER RE, CANNON PJ. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 1998; 65: 804804.
- 47 DEVLIN J, PALMER RMJ, GONDE CE et al. Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation 1994; 58: 592592.
- 48 KOGLIN J, GLYSING-JENSEN T, MUDGETT JS, RUSSELL ME. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation 1998; 97: 20592059.
- 49 BEHBOO R, LANCASTER JR, JR NUSSLER AK, KORBANIC C, RAO AS, RICORDI C. Nitric oxide production increases with intraportal islet xenograft transplantation. Transplant Proc 1994; 26: 34483448.
- 50 BEHBOO R, LANCASTER JR Jr, SWEETLAND M et al. Nitric oxide generation following intrahepatic human-to-rat islet transplantation is blocked by NG-monomethyl-L-arginine. Transplant Proc 1994; 26: 776776.
- 51 BENVENUTI C, BORIES PH, LOISANCE D. Increased serum nitrate concentration in cardiac transplant patients. A marker for acute allograft cellular rejection. Transplantation 1996; 61: 745745.
- 52 LANGHREHR JM, MURASE N, MARKUS PM et al. Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest 1992; 90: 679679.
- 53 WORALL NK, LAZENBY WD, MISKO TP et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995; 181: 6363.
- 54 SALKOWSKI CA, DETORE G, MCNALLY R, VAN R OOIJEN N, VOGEL SN. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo. The roles of macrophages, endogenous IFN-γ, and TNF receptor-1-mediated signaling. J Immunol 1997; 158: 905905.
- 55 STUEHR DJ, MARLETTA MA. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-γ. J Immunol 1987; 139: 518518.
- 56 WU G, KORSGREN O, ZHANG J, SONG Z, VAN R OOIJEN N, TIBELL A. Pig islet xenograft rejection is markedly delayed in macrophage-depleted mice: a study in streptozotocin diabetic animals. Xenotransplantation 2000; 7: 214214.
- 57 VAN DER V EEN RC, DIETLIN TA, GRAY JD, GILMORE W. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. Cell Immunol 2000; 199: 4343.DOI: 10.1006/cimm.1999.1597
- 58 LANGREHR JM, DULL KE, OCHOA JB et al. Evidence that nitric oxide production by in vivo allosensitized cells inhibits the development of allospecific CTL. Transplantation 1992; 53: 632632.
- 59 TSAO PS, WANG B-Y, BUITRAGO R, SHYY JY-J, COOKE JP. Nitric oxide regulates monocyte chemotactic protein-1. Circulation 1997; 96: 934934.